The interactions of local guanethidine and sympathomimetic amines in the human eye.
D000661:Amphetamine / Q000494:pharmacology; D004357:Drug Synergism; D004809:Ephedrine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005128:Eye Diseases / Q000188:drug therapy; D005143:Eyelids; D006145:Guanethidine / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D008729:Methoxamine / Q000494:pharmacology; D010633:Phenmetrazine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011680:Pupil / Q000187:drug effects*; D013562:Sympathectomy; D013565:Sympatholytics / Q000494:pharmacology / Q000627:therapeutic use; D013566:Sympathomimetics / Q000494:pharmacology*
D013565:Sympatholytics; D013566:Sympathomimetics; D010656:Phenylephrine; D000661:Amphetamine; D004809:Ephedrine; D008729:Methoxamine; D010633:Phenmetrazine; D004837:Epinephrine; D006145:Guanethidine